The No. 1 consumer goods company will acquire Aimmune Therapeutics, a biopharmaceutical company developing and commercializing treatments for food allergies, in a deal valued at $2.6 billion.
The merger expands its engineering services portfolio by strengthening presence in medical devices, consumer and industrial markets across the United States.
The completed transaction introduces Utz as a publicly listed company on the New York Stock Exchange after nearly 100 years as a family-owned business.
The newly combined solution is expected to deliver best-in-class sales enablement and efficiency for CPG brands seeking sales and finance process and performance improvements.
The addition of CREMO’s “barber-grade” beard, hair, shave prep and skin care products will complement such other Edgewell brands as Jack Black and Bulldog.
